October 29, 2021 at 09:40PM FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age

FDA authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include children 5 through 11 years of age.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3nDoe45

October 29, 2021 at 08:09PM BIMO/Team Biologics/Internet Surveillance/Other

This is the main page for the CBER BIMO/Team Biologics/Internet Surveillance/Other.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2KKaoKw

October 29, 2021 at 04:34PM Roster of the Vaccines and Related Biological Products Advisory Committee

This is the Roster of the Vaccines and Related Biological Products Advisory Committee

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2LdRQ7c

October 29, 2021 at 04:34PM Roster of the Blood Products Advisory Committee

This is the Roster of the Blood Products Advisory Committee (BPAC).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2JHpvD1

Thursday, October 28, 2021

October 28, 2021 at 08:58PM KOVALTRY

KOVALTRY®, Antihemophilic Factor (Recombinant), is a recombinant,
human DNA sequence derived, full length Factor VIII concentrate indicated
for use in adults and children with hemophilia A (congenital Factor VIII
deficiency) for:
 On-demand treatment and control of bleeding episodes
 Perioperative management of bleeding
 Routine prophylaxis to reduce the frequency of bleeding episodes

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2nxbn80

October 28, 2021 at 05:31PM Exceptions and Alternative Procedures Approved Under 21 CFR 640.120

Title 21 Code of Federal Regulations 640.120(a) - The Director, Center for Biologics Evaluation and Research, may approve an exception or alternative procedures to any requirement in subchapter F (Biologics) of Chapter I (Parts 600 - 680) of title 21 of the Code of Federal Regulations regarding bloo

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2ZCEYhG

October 28, 2021 at 04:54PM Berinert

Product approval information is indicated for treatment of acute abdominal or facial attacks of hereditary angioedema (HAE) in adult and adolescent patients.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3hEduAd

Tuesday, October 26, 2021

October 26, 2021 at 11:27PM Remarks by Acting Commissioner Janet Woodcock to the FDA Pharmaceutical Quality Symposium 2021: Innovations in a Changing World - 10/26/2021

Remarks by Janet Woodcock, M.D.
Acting Commissioner of Food and Drugs
FDA Pharmaceutical Quality Symposium 2021: Innovations in a Changing World
October 26, 2021
White Oak, MD

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3npKyOg

October 26, 2021 at 09:20PM Licensed Biological Products with Supporting Documents

Licensed biological products with supporting documents is arranged alphabetically by the proper name of the product(s). Information is provided for original product approvals, new indications, and the current package insert.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2mlPLLB

October 26, 2021 at 09:04PM Davati Medical Supply LLC - 615530 - 10/14/2021

Unapproved and Misbranded Product Related to Influenza Virus

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3mgn52P

October 26, 2021 at 09:03PM Davati Medical Supply LLC - 615530 - 06/25/2021

Unapproved and Misbranded Product Related to Influenza Virus

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3yvXINB

Thursday, October 21, 2021

October 21, 2021 at 08:31PM Pregnant? Breastfeeding? Better Drug Information Is Coming

The Food and Drug Administration is helping women and their health care providers to learn more about the effects of medicines during pregnancy and breastfeeding.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3b02ZDA

October 21, 2021 at 05:24PM Staff Fellow – Bioinformatics Reviewer

The FDA’s Center for Biologics Evaluation and Research (CBER), Office of Tissues and Advanced Therapies (OTAT), Division of Cellular and Gene Therapies (DCGT) is recruiting a full-time Bioinformatics Reviewer to fill a staff fellow position.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3EipFM7

October 21, 2021 at 02:49PM Data Standards for Drug and Biological Product Submissions Containing Real-World Data

Data Standards for Drug and Biological Product Submissions Containing Real-World Data

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3nftJWj

October 20, 2021 at 10:51PM Coronavirus (COVID-19) Update: FDA Takes Additional Actions on the Use of a Booster Dose for COVID-19 Vaccines

The FDA took additional actions regarding booster doses of COVID-19 vaccines, including authorizing heterologous (or “mix and match”) booster doses in eligible individuals following completion of primary vaccination with a different available COVID-19 vaccine.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3DUwgfa

October 20, 2021 at 09:48PM Remarks by Acting Commissioner Woodcock to the 2021 NORD Breakthrough Summit - 10/19/2021

Remarks by Janet Woodcock, MD
Acting Commissioner of Food and Drugs
2021 NORD Breakthrough Summit
October 19, 2021
Washington, DC

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3ngTZzP

Tuesday, October 19, 2021

October 19, 2021 at 11:49PM Multilingual COVID-19 Resources

The U.S. Centers for Disease Control and Prevention (CDC), and international and U.S. Government partners including FDA, are addressing an outbreak of coronavirus disease 2019 (COVID-19).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3bey6d4

October 18, 2021 at 07:06PM Training Course: Achieving Data Quality and Integrity in Maximum Containment Laboratories

To help address challenges associated with ensuring data quality and integrity in regulated studies conducted in BSL-4 laboratories to support MCM development, FDA and UTMB collaborate to provide an annual training course on how to meet GLP requirements in BSL-4 facilities

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/30kpooc

Friday, October 15, 2021

October 15, 2021 at 07:53PM Contacts in the Center for Biologics Evaluation & Research (CBER)

List of contact information in the Center for Biologics Evaluation & Research (CBER)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2ONy8CT

October 15, 2021 at 02:55PM Flucelvax Quadrivalent

For active immunization of children and adolescents 4 years of age and older for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2REAPn2

Thursday, October 14, 2021

October 14, 2021 at 03:45PM Xenotransplantation Guidances

This page contains a listing of xenotransplantation guidances.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/393I5RA

October 13, 2021 at 05:38PM Fast Track Designation Request Performance

The Food and Drug Administration Modernization Act of 1997 (FDAMA) includes Section 112, "Expediting study and approval of fast track drugs." This section mandates the Agency to facilitate the development and expedite review of drugs and biologics intended to treat serious or life-threatening conditions and that demonstrate the potential to address unmet medical needs. Fast track adds to existing programs, such as accelerated approval, the possibility of a "rolling submission" for a marketing application. An important feature of fast track is that it emphasizes the critical nature of close early communication between the FDA and sponsor to improve the efficiency of product development.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2N7vN39

October 13, 2021 at 03:01PM Select Updates for Unique Device Identification: Policy Regarding Global Unique Device Identification Database Requirements for Certain Devices

This draft guidance explains that there are certain class I devices for which FDA does not intend to enforce GUDID submission requirements.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2YLx5aR

Tuesday, October 12, 2021

October 12, 2021 at 06:12PM OBIZUR

Product approval information is indicated for the treatment of bleeding episodes in adults with acquired hemophilia A.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2nfOUMu

October 12, 2021 at 05:44PM Biosimilar and Interchangeable Biologics: More Treatment Choices

The FDA has approved biosimilar medications to treat conditions such as cancer, diabetes, Crohn’s disease, colitis, rheumatoid arthritis, psoriasis, and more.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2QFSPOz

October 09, 2021 at 12:01AM Moderna COVID-19 Vaccine

Information about the Moderna COVID-19 Vaccine

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3rlqM82

Thursday, October 7, 2021

October 08, 2021 at 01:57AM 2021_10 Test Article FT 01

2021_10 Test Article some long description some long description.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3mAzEEZ

Wednesday, October 6, 2021

October 06, 2021 at 10:40PM PREA Non-Compliance Letters

PREA Non-Compliance Letters

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3iaguUn

October 06, 2021 at 07:15PM Remarks by Acting Commissioner Woodcock at the Global Summit on Regulatory Science Research - 10/05/2021

Remarks by Janet Woodcock, MD
Acting Commissioner of Food and Drugs
Global Summit on Regulatory Science Research
National Center for Toxicological Research
Jefferson, Arkansas
October 5, 2021

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2YoriYK

October 06, 2021 at 02:45PM Beware of Fraudulent Coronavirus Tests, Vaccines and Treatments

Fraudulent products that claim to cure, treat, or prevent COVID-19 haven’t been evaluated by the FDA for safety and effectiveness and might be dangerous to you and your family.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3btZ1kZ

Tuesday, October 5, 2021

October 05, 2021 at 04:37PM Biosimilars Guidances

This page lists Biosimilars Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3uHgxNr

October 05, 2021 at 08:55PM Regenerative Medicine Advanced Therapy Designation

Eligibility requirements for a regenerative medicine advanced therapy (RMAT) designation. Information on when and where to submit the request is also provided.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2I3jrEY

October 05, 2021 at 07:57PM Preguntas y respuestas sobre Comirnaty (Vacuna de ARNm contra el COVID-19)

La FDA llevó a cabo una evaluación exhaustiva de los datos y la información presentados en la Solicitud de Licencia Biológica (BLA, por sus siglas en inglés). para Comirnaty antes de tomar la determinación de que la vacuna es segura y eficaz para prevenir el COVID-19 en personas de 16 años y mayores

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3BlnVQn

October 05, 2021 at 05:08PM Guidance and Other Information of Special Interest to MCM Stakeholders

Information of particular interest to sponsors/applicants of medical countermeasures to treat, prevent, diagnose, and detect chemical, biological, radiological, and nuclear threats and emerging infectious diseases

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2RGjD0A

October 05, 2021 at 04:49PM Antimicrobial Resistance Information from FDA

Antimicrobial resistance (AMR)—the ability of a microorganism (bacteria, virus, fungi, parasite) to resist the effects of a drug—is a serious, complex and costly public health problem. Learn what FDA is doing to address AMR.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/32B6bAj

Monday, October 4, 2021

October 04, 2021 at 11:02PM Vaccines and Related Biological Products Advisory Committee October 26, 2021 Meeting Announcement - 10/26/2021 - 10/26/2021

This is the CBER Vaccines and Related Biological Products Advisory Committee October 26, 2021 Meeting Announcement.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3moIEwX

October 04, 2021 at 09:35PM Janssen COVID-19 Vaccine Frequently Asked Questions

Answers to frequently asked questions about FDA's Emergency Use Authorization of the Janssen COVID-19 Vaccine, manufactured by Janssen Biotech, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3jsI7tN

October 04, 2021 at 06:50PM Acceptance Review for De Novo Classification Requests

This guidance discusses De Novo acceptance policies and procedures, Refuse to Accept principles, and the Acceptance Checklist for De Novo Requests.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3m4vmnr

October 04, 2021 at 03:53PM De Novo Classification Process (Evaluation of Automatic Class III Designation)

The purpose of this document is to provide guidance on the process for the submission and review of a De Novo classification request. 

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3a2MjLa

Friday, October 1, 2021

October 01, 2021 at 10:16PM CBER Service Fellowship Program

provides a mechanism for the temporary employment, training, and professional development of promising postdoctoral scientists for a period of limited duration.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3ipYUg3

October 01, 2021 at 10:04PM Joint Statement from HHS Public Health and Medical Experts on COVID-19 Booster Shots

Public health and medical experts from the U.S. Department of Health and Human Services released a statement on the Administration’s plan for COVID-19 booster shots for the American people.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3y4vd9u

October 01, 2021 at 10:04PM Vaccines and Related Biological Products Advisory Committee October 14-15 , 2021 Meeting Announcement - 10/14/2021 - 10/15/2021

This is the CBER Vaccines and Related Biological Products Advisory Committee October 14-15 , 2021 Meeting Announcement.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/39Vhxnx

October 01, 2021 at 08:48PM CBER Reports

This page contains a summary of regulatory, research, and administrative accomplishments for the last 2 fiscal years and related reports.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2OUkcnu

October 01, 2021 at 08:12PM FDA to Hold Advisory Committee Meetings to Discuss Emergency Use Authorization for Booster Doses and COVID-19 Vaccines for Younger Children

The FDA is announcing two upcoming meetings of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) to discuss newly available data for the currently available COVID-19 vaccines.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3l1TYjm

October 01, 2021 at 04:12PM DG Gel Card 125445, 125449, 125450 - 125457

Product approval information is for:
•DG Gel 8 AB (x4) card is for the determination of human A and B antigen on the surface of red blood cells in four separate blood samples. For use with the DG Gel System. For in vitro diagnostic use.
•DG Gel 8 A/B/D card is for the determination of human A, B and D antigens on the surface of red blood cells in two separate blood samples. For use with the DG Gel System. For in vitro diagnostic use.
•DG Gel 8 ABO/Rh + Kell card is for the determination of ABO forward and reverse grouping, and D and Kell antigens on the surface of red blood cells in human blood samples. For use with the DG Gel System. For in vitro diagnostic use.
•DG Gel 8 Rh Pheno card is for the determination of human C, E, c, and e antigens on the surface of red blood cells in two separate blood samples. For use with the DG Gel System. For in vitro diagnostic use.
•DG Gel 8 T/S Mono card is for the determination of human A, B and D antigens on the surface of red blood cells, and for Indirect Antiglobulin Test in human blood samples. This assay does not contain antibodies to complement components. For use with the DG Gel System. For in vitro diagnostic use.
•DG Gel 8 Anti-IgG (Rabbit) card is for the Direct and Indirect Antiglobulin Test of human blood samples. This test does not contain antibodies to complement components.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2sevVET

October 01, 2021 at 03:14PM FDALabel: Full-Text Search of Drug Product Labeling

FDALabel Database is a web-based application that allows users to perform customizable searches of a database containing over 140,000 labeling documents for FDA-approved drug products, including human and animal prescription and over-the-counter drugs, biological products, and medical devices.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3qVNX7f

October 01, 2021 at 01:13PM Biological Product Deviation Reporting -- Blood Product Codes

This is the main page for the Biological Product Deviation Reporting - Blood Product Codes.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2n33vLQ

October 01, 2021 at 01:08PM Biological Product Deviation Reporting and HCT/P Deviation Reporting -- Non-Blood Product Codes

This is the main page for the Biological Product Deviation Reporting and HCT/P Deviation Reporting -- Non-Blood Product Codes.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2oJ6bi4

October 01, 2021 at 01:05PM Biological Product Deviation Reporting and HCT/P Deviation Reporting -- Deviation Codes

Use the following list of Biological Product Deviation (BPD) Codes to assign a specific code to a reportable event when you submit the report to FDA. Use the guidance document, "Biological Product Deviation Reporting for Blood and Plasma Establishments," (https://ift.tt/2oKXjsp) to determine if you must report an event. The list includes deviations from regulations, standards, and standard operating procedures (SOPs) that may affect the safety, purity, or potency of a product. These codes may not apply to all establishments because they include deviations and unexpected events related to SOPs implemented at individual establishments and may not be an industry standard or a procedure at your facility. The use of BPD Codes will assist the FDA in analyzing the data submitted and streamline the trend analysis.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2nUNEPw